reports
Form 8.3 - Apex Fundrock Limited : Re Redcentric plc
Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Re Redcentric plc 03-Jun-2024 / 13:34 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(...
German American Bancorp, Inc. announces the sale of the assets of Germ...
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to Hilb Group JASPER, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (Nasdaq: GABC) today announced and closed the sale of the assets of its wholly-owned subsidiary German American Insurance (GAI) to Hilb Group, an industry-leading insurance broker. The all-cash transaction is for $40 million, and creates a significant after-tax gain, net of transaction costs, of approximately $27 million. The purchase price represents approximately four times 2023 GAI revenues and appr...
GDS to Hold Annual General Meeting on June 27, 2024
GDS to Hold Annual General Meeting on June 27, 2024 SHANGHAI, June 03, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced that it will hold its 2024 Annual General Meeting of Shareholders (the “AGM”) at Garden Suite, Mandarin Oriental, Singapore, 5 Raffles Avenue, Singapore at 4:00 p.m. (China Standard Time) on June 27, 2024 (which is 4:00 a.m. (Eastern Daylight Time) on June 27, 2024). Holders of the Company’s ord...
National Bank Of Bahrain: 1 director
A director at National Bank Of Bahrain sold 18,281 shares at 0.550BHD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
KE Holdings Inc: 2 directors
Two Directors at KE Holdings Inc sold 2,814,900 shares at between 5.633USD and 5.675USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
State Street Global Advisors Study: Advisors Capture Four Influential ...
BOSTON--(BUSINESS WIRE)-- State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), released the results of its , a comprehensive analysis of four investor groups demonstrating significant and enduring growth. This study aims to equip advisors with invaluable insights into the evolving needs and preferences of these high-potential segments, empowering them to position their practices for long-term success. This press release features multimedia. View the full release here: As millennials accumulate wealth and navigate increasingly complex financial n...
electroCore, Inc. Announces $9.3 Million Registered Direct Offering an...
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock. T...
Beyond, Inc. to Participate in Upcoming Investor Conferences
Beyond, Inc. to Participate in Upcoming Investor Conferences MIDVALE, Utah, June 03, 2024 (GLOBE NEWSWIRE) -- Beyond, Inc. (NYSE:BYON), owner of Overstock, Bed Bath & Beyond, Zulily, and other online retail brands designed to unlock your home’s potential, today announced that the company will be participating in the following investor events: UBS Consumer Insights Day, with virtual participation and a fireside chat on June 13, 2024 at 11:30 a.m. ET. This fireside chat will be webcast to UBS clients only.Jefferies Consumer Conference in Nantucket on June 17-18, 2024. This conference is no...
KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024...
KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024 Annual Meeting of Shareholders MISSISSAUGA, Ontario, June 03, 2024 (GLOBE NEWSWIRE) -- KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) would like to remind shareholders to vote in connection with the Company’s upcoming annual meeting of shareholders (the “Meeting”), to be held on Tuesday, June 11, 2024 at 2:00 PM ET. Shareholders are advised to vote their shares well in advance of the proxy voting deadline of Friday, June 7, 2024 at 2:00 PM ET. YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD.PLEASE VOTE YO...
Papiers Tissu KP rappelle aux actionnaires de voter avant l'échéance p...
Papiers Tissu KP rappelle aux actionnaires de voter avant l'échéance pour l'assemblée annuelle des actionnaires de 2024 MISSISSAUGA, Ontario, 03 juin 2024 (GLOBE NEWSWIRE) -- Papiers Tissu KP inc. (« PTKP » ou la « Société ») (TSX : KPT) souhaite rappeler aux actionnaires de voter dans le cadre de la prochaine assemblée annuelle des actionnaires de la Société (l'« assemblée »), qui se tiendra le mardi 11 juin 2024 à 14 heures (heure de l'Est). Il est conseillé aux actionnaires de voter leurs actions bien avant la date limite de vote par procuration, fixée au vendredi 7 juin 2024 à 14h00 E...
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schell...
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer PASADENA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- . (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy and immunotherapy, today announced the appointment of Jan Schellens, M.D., Ph.D., as Chief Medical Officer (CMO). Dr. Schellens brings to LIXTE more than 25 years of clinical experience as a medical oncologist, pharmacologist and clinical pharmacologist, including more than two de...
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Pl...
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device Clinical studies in anxiety and insomnia expected to commence in the third quarter of 2024 HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided feedback and reached consensus on the design for its planned clinical studies in anxiety and insomnia for its new Gen-3 HALO Clarity™ (“HALO”), a non-in...
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ s...
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform The integrated aPROMISE solution to be demonstrated on Siemens Healthineers’ syngo.via platform at the SNMMI annual meeting BEDFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that aPROMISE, its AI-enabled FDA-cleared medical device software, is now available on the syngo.via platform, ...
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid ...
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement BEIJING, June 03, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on May 29, 2024, informing the Company that it has regained compliance with Nasdaq's minimum bid pr...
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, A...
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles Innovative Formula To Be Available in Portable Format for Enhanced Accessibility and Convenience JUPITER, FL, June 03, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today the launch of its revolutionary formula in new, convenient 4-ounce bottles. Designed for easy on-the-go use, this new format ensures that customers can enjoy the benefits of Safety Shot's groundbreaking formula anytime, anywhere. Safety Shot is a first of its kind functional...
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal...
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k) submission BRAINTREE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces that it has received the U.S. Food and Drug Administration’s (“FDA”) approval to proceed with its pivotal h...
- Brian Moretta
Eos Innovation Fund - Eos Advisory LLP
The Eos Innovation Fund invests primarily in Scottish-based unquoted science, engineering or technology companies with an impact aim. It focuses on four areas of investment, where it believes it can have the most impact. Its strongest area of dealflow has been in life sciences. The manager arose out of an angel network based in St Andrews and has quickly built both a solid sourcing capacity and multi-stranded support capability. Having only been investing since 2015, the exit track record is ine...
Bezeq The Israel Telecomunication Corp Ltd: 1 director
A director at Bezeq The Israel Telecomunication Corp Ltd bought 990,947 shares at 4.470ILS and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Egyptian For Tourism Resorts: 1 director
A director at Egyptian For Tourism Resorts bought 3,585,000 shares at 0.000EGP and the significance rating of the trade was 92/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
United Energy Group Ltd: 1 director
A director at United Energy Group Ltd sold 58,000,000 shares at 0.630HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.